Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 14, 2019

SELL
$8.75 - $12.85 $934,045 - $1.37 Million
-106,748 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$12.3 - $35.76 $1.31 Million - $3.82 Million
106,748 New
106,748 $1.36 Million
Q4 2017

Feb 14, 2018

SELL
$93.85 - $132.45 $11.8 Million - $16.6 Million
-125,358 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$72.0 - $119.75 $9.03 Million - $15 Million
125,358
125,358 $15 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $132M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.